Cytokine patterns in experimental schistosomiasis mansoni infected mice treated with silymarin

  title={Cytokine patterns in experimental schistosomiasis mansoni infected mice treated with silymarin},
  author={Nagwa Mostafa El-Sayed and Ghada Fathy and Sara A. Abdel-rahman and Mahmoud Abdel-Atei El-Shafei},
  journal={Journal of Parasitic Diseases},
The purpose of this study was to determine cytokine patterns in experimental schistosomiasis mansoni infected mice treated with silymarin. The study was conducted upon 100 mice that were divided into five groups; 20 each: uninfected control group, Schistosomamansoni infected untreated mice (infected control), infected mice treated with praziquantel (PZQ), infected mice treated with silymarin and infected mice treated with both praziquantel and silymarin. 10 mice from each group were sacrificed… 

Modulation of mice immune responses against Schistosoma mansoni infection with anti-schistosomiasis drugs: Role of interleukin-4 and interferon-gamma

It is indicated that anti-schistosomiasis drugs ART, ARA, and PZQ play a role in the modulation of expression of Th2 cytokines and Th1 cytokine under the effect of anti-Schistosomal drugs.

Enhancement of the therapeutic efficacy of praziquantel in murine Schistosomiasis mansoni using silica nanocarrier

The results indicate that mesoporous silica NP is a promising safe nanocarrier for PZQ potentiating its antischistosomal, antioxidant, immunomodulatory, and anti-inflammatory action in animal model infected with S. mansoni.

Immunopathological effects of some Biomphalaria pfeifferi proteins against Schistosoma mansoni infection in BALB/c mice

The results show the proteins were efficacious with foot and digestive gland soluble proteins having 59.1 and 40.9% worm reduction, respectively and stimulated the production of effective cytokines, immunoglobulins and reduced hepatic pathology.

Investigating in vitro anti-leishmanial effects of silibinin and silymarin on Leishmania major

It is demonstrated that both medications have suitable effects like Glucantime® on the parasite in vitro and clinical assessment of the anti-leishmanial activity of silibinin and silymarin for treating the dermal lesions caused by L. major is recommended.

The role of microRNAs in the pathogenesis, grading and treatment of hepatic fibrosis in schistosomiasis

A balanced and comprehensive view of the role of miRNAs in the pathogenesis, grading, and treatment of schistosomiasis-associated hepatic fibrosis is presented.

Efficiency of Three Extracts of Carica papaya as Molluscicidal and Anti-schistosomal Agents against Biomphalaria alexandrina and Schistosoma mansoni by Flow Cytometry

The in-vivo results showed that the three extracts have variable potential against snails and miracidia and cercariae of S. mansoni and methanol extract was more effective at concentration of LC50 180 and LC90 220 than ethanol and butanol extracts of Carica papaya.

Evaluation of Poly lactide-co-glycolide Acid [PLGA] Nanoparticles Loaded with Praziquantel in treatment of experimental murine Schistosomiasis mansoni.

Evaluated the in vivo antischistosomal effects of praziquantel-loaded PLGA NPs compared to pZQ in treatment of experimental murine Schistosomiasis mansoni as regards of worm burden, oogram pattern, tissue egg load, liver enzymes status, cytokines changes, and histopathological studies.

Silymarin: not just another antioxidant

This review aims at demonstrating the main protective activities of SM in diseases, such as cancer, diabetes, hepatitis, non-alcoholic fatty Liver disease, alcoholic liver disease, hepatitis C virus, hepatitis B virus, metabolic syndrome, depression, cardiovascular diseases and thalassemia, in addition to its photoprotective activity in in vitro tests and preclinical studies.



Cytokine Production Associated with Periportal Fibrosis during Chronic Schistosomiasis Mansoni in Humans

Univariate analysis identified associations of age, sex, intensity of infection, and absence of eggs/g of feces with moderate/severe fibrosis and an association ofintensity of infection with incipient fibrosis with IL-13.

Silymarin treatment reduces granuloma and hepatic fibrosis in experimental schistosomiasis

Treatment with silymarin at acute phase of schistosomiasis may result in a mild course of murine schistOSomiasis and can be a promising complementary treatment reverting sequelae of this infection.

Association of Type 2 Cytokines with Hepatic Fibrosis in Human Schistosoma mansoni Infection

A role for type 2 cytokines in hepatic fibrosis in human schistosomiasis mansoni is suggested, particularly in subjects who remained untreated for 1 year following initial assessment and developed more serious fibrosis during this period.

The role of cytokines in the formation of the schistosome egg granuloma.

  • D. Boros
  • Medicine, Biology
  • 1994

Studies of murine schistosomiasis reveal interleukin‐13 blockade as a treatment for established and progressive liver fibrosis

It is shown that interleukin (IL)‐13 is required at all stages of Schistosomiasis mansoni infection to induce fibrosis, and therapeutic approaches aimed at disrupting the IL‐13 pathway will be highly effective at preventing fibrotic disease caused by chronic Th2‐mediated inflammatory reactions.

Effect of Chemotherapy with Praziquantel on the Production of Cytokines and Morbidity Associated with Schistosomiasis Mansoni

The data suggest that chemotherapy is effective in reducing the morbidity of the disease and that the level of IL-13 may be a useful indicator of the persistence of fibrosis following treatment.

Cytokine Regulation of Periportal Fibrosis in Humans Infected with Schistosoma mansoni: IFN-γ Is Associated with Protection Against Fibrosis and TNF-α with Aggravation of Disease1

Results with observations in experimental models strongly suggest that IFN-γ plays a key role in the protection of S. mansoni-infected patients against periportal fibrosis, whereas TNF-α may aggravate the disease.

Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease.

Results with observations in experimental models strongly suggest that IFN-gamma plays a key role in the protection of S. mansoni-infected patients against periportal fibrosis, whereas TNF-alpha may aggravate the disease.